Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases

Gut

Volumn 46, Issue 3, 2000, Pages 359-366

  Petretti, T ^a   Kemmner, W ^a   Schulze, B ^a   Schlag, P M ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Adenomas; Colorectal carcinoma; Glycosyltransferases; Liver metastasis; mRNA expression; Tumour prognosis

Indexed keywords

FUCOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE; SIALYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARBOHYDRATE SYNTHESIS; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GLYCOSYLTRANSFERASES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALYLTRANSFERASES;

EID: 0034021674     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.3.359     Document Type: Article

References (56)

1. Taniguchi N, Yoshimura M, Miyoshi E, et al. Remodeling of cell surface glycoproteins by N-acetylglucosaminyl-transferase III gene transfection: Modulation of metastatic potentials and down regulation of hepatitis B virus replication. Glycobiology 1996;6:691-4.
2. Hiraiwa N, Dohi T, Kawakami Kimura N, et al. Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an alpha13 fucosyltransferase (Fuc-T VII). J Biol Chem 1996;271:31556-61.
3. Paulson JC, Weinstein J, Schauer A. Tissue-specific expression of sialyltransferases. J Biol Chem 1989;264:10931-4.
4. O'Hanlon TP, Lau KM, Wang XC, et al. Tissue-specific expression of β-galactoside alpha 2,6-sialyltransferase. J Biol Chem 1989;264:17389-94.
5. Dall'Olio F, Malagolini N, DiStefano G, et al. Increased CMP-NeuAc: Galβ1, 4GlcNAc-R α2, 6-sialyltransferase activity in human colorectal cancer tissues. Int J Cancer 1989; 44:434-9.
6. Gessner P, Riedl S, Quentmaier A, et al. Enhanced activity of CMP-NeuAc: Galbeta 1-4GlcNAc: Alpha 2,6- sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett 1993;75:143-9.
7. Dall'Olio F, Malagolini N, Serafini Cessi F. Enhanced CMP-NeuAc: Galbetal, 4GlcNAc-R alpha 2,6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines. Int J Cancer 1992;50:325-30.
8. Bosch J, Brossmer R, Kemmner W, et al. Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens. Cancer Detect Prev 1998;22:319-29.
9. Morgenthaler J, Kemmner W, Brossmer R. Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b. Biochem Biophys Res Commun 1990;171:860-6.
10. Pilatte Y, Bignon J, Lambre CR. Sialic acids as important molecules in the regulation of the immune system: Pathophysiological implications of sialidases in immunity. Glycobiology 1993;3:201-17.
11. Kemmner W, Kruck D, Schlag P. Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors. Clin Exp Metastasis 1994;12:245-54.
12. Ito H, Hiraiwa N, Sawada Kasugai M, et al. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer 1997;71:556-64.
13. Whitehouse C, Burchell J, Gschmeissner S, et al. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-golgi apparatus inhibits the development of core-2-based O-glycans. J Cell Biol 1997;137:1229-41.
14. Recchi MA, Hebbar M, Hornez L, et al. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 1998;58:4066-70.
15. Natsuka S, Lowe JB. Enzymes involved in mammalian oligosaccharide biosynthesis. Curr Opin Struct Biol 1994;4: 683-91.
16. Dennis JW. N-linked oligosaccharide processing and tumor cell biology. Semin Cancer Biol 1991;2:411-20.
17. Demetriou M, Nabi IR, Coppolino M, et al. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 1995;130: 383-92.
18. Reference withdrawn.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
20. Orntoft TF, Vestergaard EM. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999; 20:362-71.
21. Kemmner W, Hohaus K, Schlag PM. Inhibition of Gal beta1, 4GlcNAc alpha2,6 sialyltransferase expression by antisense-oligodeoxynucleotides. Febs Lett 1997;409: 347-50.
22. Dennis JW, Laferte S, Waghorne C, et al. β1-6 branching of ASN-linked oligosaccharides is directly associated with metastasis. Science 1987;236:582-5.
23. Korczak B, Goss P, Fernandez B, et al. Branching N-linked oligosaccharides in breast cancer. Adv Exp Med Biol 1994; 353:95-104.
24. Li WP, Zuber C, Heitz PU, et al. Cytochemical staining for beta 1,6 branching of asparagine-linked oligosaccharides in variants of metastatic human colon carcinoma cells. Am J Pathol 1994;145:470-80.
25. Fernandes B, Sagman U, Auger M, et al. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 1991;51: 718-23.
26. Seelentag WK, Li WP, Schmitz SF, et al. Prognostic value of beta 1, 6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 1998;58:5559-64.
27. Schauer R. Biosynthesis and function of N- and O-substituted sialic acids. Glycobiology 1991;1:449-52.
28. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 1997;14: 577-84.
29. Kudo T, Ikehara Y, Togayachi A, et al. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 1998;78:797-811.
30. Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science 1997;276:1268-72.
31. Larsen RD, Ernst LK, Nair RP, et al. Molecular cloning, sequence, and expression of a human GDP-L-fucose: Beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 1990;87:6674-8.
32. Kelly RJ, Rouquier S, Giorgi D, et al. Sequence and expression of a candidate for the human secretor blood group alpha (1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995;270:4640-9.
33. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52: 257-331.
34. Oriol R, Mollicone R, Coullin P, et al. Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMIS Suppl 1992;27:28-38.
35. Matsumoto H, Muramatsu H, Shimotakahara T, et al. Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas. Cancer 1993;72:75-81.
36. Orntoft TF, Meldgaard P, Pedersen B, et al. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res 1996;56:1031-6.
37. Orntoft TF, Greenwell P, Clausen H, et al. Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation. Gut 1991;32:287-93.
38. Sun J, Thurin J, Cooper HS, et al. Elevated expression of H type GDP-L-fucose: Beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci USA 1995;92:5724-8.
39. Goupille C, Hallouin F, Meflah K, et al. Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection. Glycobiology 1997;7:221-9.
40. Kukowska Latallo JF, Larsen RD, Nair RP, et al. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1, 4)fucosyltransferase. Genes Dev 1990;4:1288-303.
41. Kumar R, Potvin B, Muller WA, et al. Cloning of a human alpha(1,3)-fucosyltransferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J Biol Chem 1991;266:21777-83.
42. Lowe JB, Kukowska Latallo JF, Nair RP, et al. Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J Biol Chem 1991;266: 17467-77.
43. Koszdin KL, Bowen BR. The cloning and expression of a human alpha-1,3 fucosyltransferase capable of forming the E-selectin ligand. Biochem Biophys Res Commun 1992;187: 152-7.
44. Weston BW, Nair RP, Larsen RD, et al. Isolation of a novel human alpha (1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group alpha (1, 3/1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J Biol Chem 1992;267:4152-60.
45. Natsuka S, Gersten KM, Zenita K, et al. Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 1994;269:16789-94.
46. Sasaki K, Kurata K, Funayama K, et al. Expression cloning of a novel alpha 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J Biol Chem 1994;269:14730-7.
47. Liepkalns VA, Eboue D, Beringer T, et al. Repression of the Lewis fucosyl transferase by retinoic acid increases apical sialosyl Lewis(a) secretion in colorectal carcinoma cultures. J Cell Biochem 1995;58:292-304.
48. Hanski C, Klussmann E, Wang J, et al. Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj J 1996;13:727-33.
49. Yago K, Zenita K, Ginya H, et al. Expression of alpha-(1,3)-fucosyltransferases which synthesize sialyl Le(x) and sialyl Le(a), the carbohydrate ligands for E- and P-selectins, in human malignant cell lines. Cancer Res 1993;53:5559-65.
50. Kitagawa H, Paulson JC. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem 1994;269:1394-401.
51. Kitagawa H, Paulson JC. Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. Biochem Biophys Res Commun 1993;194:375-82.
52. Sasaki K, Watanabe E, Kawashima K, et al. Expression cloning of a novel Gal beta (1 3/1 4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem 1993;268:22782-7.
53. Grundmann U, Nehrlich C, Rein T, et al. Complete cDNA sequence encoding human β-galactoside alpha 2,6- sialyltransferase. Nucleic Acids Res 1994;18:667.
54. Masri KA, Appert HE, Fukuda MN. Identification of the full-length coding sequence for human galactosyltransferase (beta-N-acetylglucosaminide: Beta 1,4-galactosyltransferase). Biochem Biophys Res Commun 1988;157:657-63.
55. Saito H, Nishikawa A, Gu J, et al. cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+. Biochem Biophys Res Commun 1994;198:318-27.
56. Ponte P, Ng SY, Engel J, et al. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1998;12: 1687-96.